SANOFICONR

Sanofi Consumer Healthcare India Ltd.

4,567.20-32.8 (-0.71%)
17 Jul, 12:00 AM

Income Statement

Abridged
Understanding Income Statement
Sanofi Consumer Healthcare India Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.
2023
Dec 31
2024
Dec 31
2025
Dec 31
TTM
Mar 31
Period length:
Source:
12M
AR
12M
AR
12M
AR
12M
IR
Total Revenue
555.40724.50878.40935.00
Cost of Operating Revenue
153.90190.70241.90260.40
Gross Profit
401.50533.80636.50674.60
Gross Margin
72.373.772.572.1
Total Operating Expenses
338.40458.40581.10614.10
Operating Profit
217.00266.10297.30320.90
Operating Margin
39.136.733.834.3
Financing Income/(Expense) - Net
4.008.0016.00-2.10
Profit before Taxes
219.30246.80320.30344.20
Income Taxes
54.4065.8080.2086.30
Profit after Tax
164.90181.00240.10257.90
PAT Margin
29.725.027.327.6
EPS - Basic - ex Extraordinary Items
71.6078.59104.27112.00
EPS - Diluted - ex Extraordinary Items
71.6078.59104.27112.00
EBIT
217.00266.10297.30320.90
EBITDA
218.80270.60309.00333.80
EBITDA Margin
39.437.335.235.7

Balance Sheet

Abridged
Understanding Balance Sheet
Sanofi Consumer Healthcare India Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.
2023
Dec 31
2024
Dec 31
2025
Dec 31
Source:
AR
AR
AR
Total Current Assets
335.20391.70494.30
Property Plant & Equipment - Net
2.0027.9035.10
Total Non-Current Assets
10.2039.6052.70
Total Assets
345.40431.30547.00
Total Current Liabilities
129.90130.60128.40
Long Term Debt
-16.6017.10
Total Non-Current Liabilities
7.9027.7034.60
Total Liabilities
137.80158.30163.00
Total Shareholders' Equity
207.60273.00384.00
Total Equity
207.60273.00384.00
Total Liabilities & Equity
345.40431.30547.00

Cash Flow

Abridged
Understanding Cash Flow Statement
Sanofi Consumer Healthcare India Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.
2023
Dec 31
2024
Dec 31
2025
Dec 31
Period length:
Source:
12M
AR
12M
AR
12M
AR
Operating CF bef Changes in Working Cap
216.90134.30241.80
Working Capital - Increase/(Decrease)
-213.30316.10-53.80
Net CF from Operating Activities
3.60450.40188.00
Capital Expenditures - Net
4.009.907.60
Net CF from Investing Activities
-4.00-9.90-7.60
Dividends Paid - Cash - Total
-115.20126.70
Stock - Issuance/(Retirement) - Net
2.00--
Debt - LT & ST - Issuance/(Retirement) - Total
---5.80
Net Cash Flow from Financing Activities
2.00-115.20-132.50
Free Cash Flow to Equity
-0.40440.50174.60
Free Operating CF net dividend
-0.40325.3053.70
Free Operating CF
-0.40440.50180.40

Business Segment Analysis

FY End:
Dec 25

Sanofi Consumer Healthcare India Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex
Total₹ 8Cr
Pharmaceutical Business (100.0%)₹ 7.60 Cr
Revenue / Sales
Total₹ 878Cr
Pharmaceutical Business (100.0%)₹ 878.40 Cr
Assets
Total₹ 547Cr
Pharmaceutical Business (100.0%)₹ 547.00 Cr
Operating Income
Total₹ 297Cr
Pharmaceutical Business (100.0%)₹ 297.30 Cr

Regional Segment Analysis

FY End:
Dec 25

Sanofi Consumer Healthcare India Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales
Total₹ 878Cr
India (81.4%)₹ 714.80 CrOutside India (18.6%)₹ 163.60 Cr

Historical Segment Analysis

Track how Sanofi Consumer Healthcare India Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Business
2023
Dec 31
2024
Dec 31
2025
Dec 31
Pharmaceutical Business4108

Frequently Asked Questions

What is the revenue of Sanofi Consumer Healthcare India Ltd.?
The latest trailing twelve month revenue of Sanofi Consumer Healthcare India Ltd. is ₹ 935.00 Cr, reflecting a 1-year growth of 36.32%. Annual and quarterly revenue trends are available in the Income Statement section.
What is the net profit of Sanofi Consumer Healthcare India Ltd.?
The latest trailing twelve month net profit (PAT) of Sanofi Consumer Healthcare India Ltd. is ₹ 257.90 Cr. Detailed profit history across annual and quarterly periods is in the Income Statement section.
What is the EBITDA of Sanofi Consumer Healthcare India Ltd.?
The trailing twelve month EBITDA of Sanofi Consumer Healthcare India Ltd. is approximately ₹ 320.90 Cr (based on an operating margin of 34.32%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.
What is the EPS of Sanofi Consumer Healthcare India Ltd.?
The trailing twelve month Earnings Per Share (EPS) of Sanofi Consumer Healthcare India Ltd. is 111.98. EPS trends across annual and quarterly periods are visible in the Income Statement section.
What is the debt level of Sanofi Consumer Healthcare India Ltd.?
The debt-to-equity ratio of Sanofi Consumer Healthcare India Ltd. stands at 0.06. The interest coverage ratio is 152.81x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.
What is the book value per share of Sanofi Consumer Healthcare India Ltd.?
The estimated book value per share of Sanofi Consumer Healthcare India Ltd. is 166.73 (derived from a P/B ratio of 27.39 and market price of ₹ 4,567.20), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.
What is the cash flow from operations of Sanofi Consumer Healthcare India Ltd.?
The trailing twelve month operating cash flow of Sanofi Consumer Healthcare India Ltd. is ₹ 188.00 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.
Does Sanofi Consumer Healthcare India Ltd. report consolidated or standalone financials?
Sanofi Consumer Healthcare India Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.